Home/Southern African Journal of Gynaecological Oncology/Article Record
Peer-Reviewed Article December 31, 2009

Cervical cancer and human papillomavirus: South African guidelines for screening and testing

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Southern African Journal of Gynaecological Oncology
Publisher: Medpharm Publications • South Africa • 2074-2835 • 2220-105X
DOI: https://doi.org/10.1080/20742835.2010.11441154

Abstract

Cervical carcinoma is still the most common cancer of women \non the African continent. Mortality remains high – worldwide at \n50% – mainly because of late presentation, advanced stage of \ndisease and absence of a functioning screening process. The \naetiological link between human papillomavirus (HPV) infection \nand cervical cancer has been well established and a number of \nhigh-risk HPV genotypes have been identified. HPV infection is \nthe most common sexually transmitted infection (STI) in the world \ntoday – up to 80% of sexually active females will harbour HPV at \nsome point in their lives. The majority of women will experience \nnatural elimination of HPV infection because of an intact immune \nsystem. Persistent infection with a high risk type HPV puts women \nat high risk to develop precursors of cervical cancer or carcinoma \nitself. As part of a public health response to this serious problem, \nseveral HPV vaccines are under development. Use of vaccines still \nposes unanswered questions in many respects.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

26
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.